Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response

@article{Li2000FunctionalLO,
  title={Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response},
  author={Shang Li and Nicholas S. Y. Ting and Lei Zheng and Phang-lang Chen and Yael Ziv and Yosef Shiloh and Eva Y.-H. P. Lee and Wen-Hwa Lee},
  journal={Nature},
  year={2000},
  volume={406},
  pages={210-215}
}
BRCA1 encodes a familial breast cancer suppressor that has a critical role in cellular responses to DNA damage. Mouse cells deficient for Brca1 show genetic instability, defective G2–M checkpoint control and reduced homologous recombination. BRCA1 also directly interacts with proteins of the DNA repair machinery and regulates expression of both the p21 and GADD45 genes. However, it remains unclear how DNA damage signals are transmitted to modulate the repair function of BRCA1. Here we show that… 
Tumour suppressors (Communication arising): Effect of DNA damage on a BRCA1 complex
TLDR
It is shown that the BRCA1–CtIP complex is stable in irradiated cells, and that the phosphorylated isoforms of CtIP that are induced by ionizing radiation still interact in vivo with B RCA1.
Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
TLDR
Elucidation of the precise molecular functions of BRCAs is expected to improve the understanding of hereditary as well as sporadic mammary carcinogenesis and protect the genome from damage.
Differing effects of breast cancer 1, early onset (BRCA1) and ataxia‐telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation
TLDR
To the authors' knowledge, this is the first demonstration of the ability of exogenously expressed BRCA1 to restore the ability to perform potentially lethal damage repair and maintain chromosomal integrity in irradiated cells.
BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance
TLDR
It is shown that cell lines and patient-derived tumors, with highly disruptive BRCT domain mutations, have readily detectable BRCA1 protein expression, and are able to proliferate in the presence of PARPi.
Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation.
TLDR
It is concluded that the inability to properly repair strand breaks by homology-directed repair gives rise to defects in chromosome maintenance that promote genetic instability and, it is likely, tumorigenesis.
Mutations in the BRCT Domain Confer Temperature Sensitivity to BRCA1 in Transcription Activation
TLDR
Random mutagenesis of the C-terminus of BRCA1 is used to generate temperature-sensitive (TS) mutants in transcription activation that localized primarily to the hydrophobic core of the BRCT-N domain of B RCA1.
A subset of ATM‐ and ATR‐dependent phosphorylation events requires the BRCA1 protein
TLDR
It is proposed that BRCA1 facilitates the ability of ATM and ATR to phosphorylate downstream substrates that directly influence cell cycle checkpoint arrest and apoptosis, but that B RCA1 is dispensable for the phosphorylation of DNA‐associated ATM andATR substrates.
BRCA1 and Its Network of Interacting Partners
TLDR
BRCA1 through its association with specific proteins and multi-protein complexes is a sentinel of the normal cell cycle control and DNA repair, and is implicated in DNA repair mechanisms and cell cycle checkpoint control.
53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
TLDR
It is shown that DNA breaks in Brca1-deficient cells are aberrantly joined into complex chromosome rearrangements by a process dependent on the nonhomologous end-joining (NHEJ) factors 53BP1 and DNA ligase 4, illustrating that HR and NHEJ compete to process DNA breaks that arise during DNA replication.
Constitutive Association of BRCA1 and c-Abl and Its ATM-Dependent Disruption after Irradiation
ABSTRACT BRCA1 plays an important role in mechanisms of response to double-strand breaks, participating in genome surveillance, DNA repair, and cell cycle checkpoint arrests. Here, we identify a
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 55 REFERENCES
Emerging roles of BRCA1 in transcriptional regulation and DNA repair
TLDR
Recently, BRCA1 was shown to repress estradiol (E2)‐responsive ER‐α‐mediated transcriptional activity, potentially linking the multiple functions of BRCa1 to specific tissue targets, an encouraging step toward understanding the role of BrcA1 in breast cancer formation.
Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.
TLDR
Results from this study indicate that the checkpoint protein kinase ATM (mutated in ataxia telangiectasia) was required for phosphorylation of Brca1 in response to ionizing radiation, which may provide a molecular explanation for the role of ATM in breast cancer.
Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.
TLDR
It is shown that BRCA1 interacts in vitro and in vivo with hRad50, which forms a complex with hMre11 and p95/nibrin that is important for the cellular responses to DNA damage that are mediated by the h Rad50-hMre 11-p95 complex.
Brca1 controls homology-directed DNA repair.
TLDR
A caretaker role for BRCA1 is demonstrated in preserving genomic integrity by promoting homologous recombination and limiting mutagenic nonhomologous repair processes.
Binding of CtIP to the BRCT Repeats of BRCA1 Involved in the Transcription Regulation of p21 Is Disrupted Upon DNA Damage*
TLDR
It is suggested that the binding of the BRCT repeats of BRCA1 to CtIP/CtBP is critical in mediating transcriptional regulation of p21 in response to DNA damage.
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl
TLDR
It is shown that BRCA1 transactivates expression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in a p53-independent manner, and that B RCA1 inhibits cell-cycle progression into the S-phase following its transfection into human cancer cells.
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
TLDR
Three participants are identified (AT gene(s), p53, and GADD45) in a signal transduction pathway that controls cell cycle arrest following DNA damage; abnormalities in this pathway probably contribute to tumor development.
Enhanced phosphorylation of p53 by ATM in response to DNA damage.
TLDR
Various damage-induced responses may be activated by enhancement of the protein kinase activity of ATM, and this activity was markedly enhanced within minutes after treatment of cells with a radiomimetic drug.
Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells.
TLDR
It is shown that mouse embryonic fibroblast cells carrying a targeted deletion of exon 11 of the Brca1 gene maintain an intact G1-S cell cycle checkpoint and proliferate poorly, however, a defective G2-M checkpoint in these cells is accompanied by extensive chromosomal abnormalities.
Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart.
  • Y. Shiloh
  • Biology, Medicine
    Annual review of genetics
  • 1997
TLDR
The recent identification of the gene responsible for Ataxia-telangiectasia, ATM, has revealed its product to be a large, constitutively expressed phosphoprotein with a carboxy-terminal region similar to the catalytic domain of phosphatidylinositol 3-Kinases (PI 3-kinases).
...
1
2
3
4
5
...